2-(Dibenzyl Amino)-1-(3,4-Dihydroxy Phenyl) Ethan-1-One Hydrochloride is a defined ionic salt form offering distinct advantages in pharmaceutical processing and performance over the free acid or base. The counter-ion in 2-(Dibenzyl Amino)-1-(3,4-Dihydroxy Phenyl) Ethan-1-One Hydrochloride has been selected based on toxicological acceptability at daily intake levels achievable from the proposed dosage regimen, and compatibility with the drug product excipient matrix.
The intraspecies uncertainty factor F2 for 2-(Dibenzyl Amino)-1-(3,4-Dihydroxy Phenyl) Ethan-1-One Hydrochloride covers the range of pharmacokinetic and pharmacodynamic variability within the human population, ensuring the derived PDE is protective for sensitive subgroups including paediatric patients with immature CYP450 activity, elderly patients
